Sort by
Items per page

Send to

Choose Destination

Best matches for NAFLD omega-3:

Search results

Items: 1 to 20 of 262


[A new attempt with lipoprotein lipase agonists in the treatment of nonalcoholic steatohepatitis].

Chen YH, Zhan Z, Hu P, Ren H, Peng ML.

Zhonghua Gan Zang Bing Za Zhi. 2019 Jul 20;27(7):533-540. doi: 10.3760/cma.j.issn.1007-3418.2019.07.011. Chinese.


Efficacy of dietary intervention and physical activity in children and adolescents with nonalcoholic fatty liver disease associated with obesity: A scoping review.

Caro-Sabido EA, Larrosa-Haro A.

Rev Gastroenterol Mex. 2019 Apr - Jun;84(2):185-194. doi: 10.1016/j.rgmx.2019.02.001. Epub 2019 May 15. Review. English, Spanish.


Diabetes Mellitus, Nonalcoholic Fatty Liver Disease, and Conjugated Linoleic Acid (Omega 6): What Is the Link?

Hegazy M, Elsayed NM, Ali HM, Hassan HG, Rashed L.

J Diabetes Res. 2019 Apr 8;2019:5267025. doi: 10.1155/2019/5267025. eCollection 2019.


Fish oil alleviates circadian bile composition dysregulation in male mice with NAFLD.

Liu Y, Li Q, Wang H, Zhao X, Li N, Zhang H, Chen G, Liu Z.

J Nutr Biochem. 2019 Jul;69:53-62. doi: 10.1016/j.jnutbio.2019.03.005. Epub 2019 Apr 4.


Dietary Docosahexaenoic Acid (DHA) and Eicosapentaenoic Acid (EPA) Operate by Different Mechanisms to Modulate Hepatic Steatosis and Hyperinsulemia in fa/fa Zucker Rats.

Hong L, Zahradka P, Cordero-Monroy L, Wright B, Taylor CG.

Nutrients. 2019 Apr 24;11(4). pii: E917. doi: 10.3390/nu11040917.


A randomized controlled trial comparing effects of a low-energy diet with n-3 polyunsaturated fatty acid supplementation in patients with non-alcoholic fatty liver disease.

Shojasaadat F, Ayremlou P, Hashemi A, Mehdizadeh A, Zarrin R.

J Res Med Sci. 2019 Mar 25;24:21. doi: 10.4103/jrms.JRMS_282_18. eCollection 2019.


Oxidative Stress and Non-Alcoholic Fatty Liver Disease: Effects of Omega-3 Fatty Acid Supplementation.

Yang J, Fernández-Galilea M, Martínez-Fernández L, González-Muniesa P, Pérez-Chávez A, Martínez JA, Moreno-Aliaga MJ.

Nutrients. 2019 Apr 18;11(4). pii: E872. doi: 10.3390/nu11040872. Review.


Fish oil protects the liver from parenteral nutrition-induced injury via GPR120-mediated PPARγ signaling.

Fell GL, Cho BS, Dao DT, Anez-Bustillos L, Baker MA, Nandivada P, Pan A, O'Loughlin AA, Mitchell PD, Nose V, Gura KM, Puder M.

Prostaglandins Leukot Essent Fatty Acids. 2019 Apr;143:8-14. doi: 10.1016/j.plefa.2019.02.003. Epub 2019 Mar 5.


Eicosapentaenoic Acid Improves Hepatic Metabolism and Reduces Inflammation Independent of Obesity in High-Fat-Fed Mice and in HepG2 Cells.

Albracht-Schulte K, Gonzalez S, Jackson A, Wilson S, Ramalingam L, Kalupahana NS, Moustaid-Moussa N.

Nutrients. 2019 Mar 12;11(3). pii: E599. doi: 10.3390/nu11030599.


Cancer-related gene expression is associated with disease severity and modifiable lifestyle factors in non-alcoholic fatty liver disease.

Arendt BM, Teterina A, Pettinelli P, Comelli EM, Ma DWL, Fung SK, McGilvray ID, Fischer SE, Allard JP.

Nutrition. 2019 Jun;62:100-107. doi: 10.1016/j.nut.2018.12.001. Epub 2018 Dec 13.


Effect of Fish Oil Supplementation on Hepatic and Visceral Fat in Overweight Men: A Randomized Controlled Trial.

Parker HM, Cohn JS, O'Connor HT, Garg ML, Caterson ID, George J, Johnson NA.

Nutrients. 2019 Feb 23;11(2). pii: E475. doi: 10.3390/nu11020475.


Changes of the Fatty Acid Profile in Erythrocyte Membranes of Patients following 6-Month Dietary Intervention Aimed at the Regression of Nonalcoholic Fatty Liver Disease (NAFLD).

Maciejewska D, Marlicz W, Ryterska K, Banaszczak M, Jamioł-Milc D, Stachowska E.

Can J Gastroenterol Hepatol. 2018 Dec 4;2018:5856201. doi: 10.1155/2018/5856201. eCollection 2018.


Omega-3 fatty acids and nonalcoholic fatty liver disease in adults and children: where do we stand?

Spooner MH, Jump DB.

Curr Opin Clin Nutr Metab Care. 2019 Mar;22(2):103-110. doi: 10.1097/MCO.0000000000000539.


n-3 Polyunsaturated fatty acids for the management of alcoholic liver disease: A critical review.

Wang M, Ma LJ, Yang Y, Xiao Z, Wan JB.

Crit Rev Food Sci Nutr. 2019;59(sup1):S116-S129. doi: 10.1080/10408398.2018.1544542. Epub 2018 Dec 22.


A review of the studies on food-derived factors which regulate energy metabolism via the modulation of lipid-sensing nuclear receptors.

Goto T.

Biosci Biotechnol Biochem. 2019 Apr;83(4):579-588. doi: 10.1080/09168451.2018.1559025. Epub 2018 Dec 20. Review.


Dietary DHA/EPA Ratio Changes Fatty Acid Composition and Attenuates Diet-Induced Accumulation of Lipid in the Liver of ApoE-/- Mice.

Liu L, Hu Q, Wu H, Wang X, Gao C, Chen G, Yao P, Gong Z.

Oxid Med Cell Longev. 2018 Nov 14;2018:6256802. doi: 10.1155/2018/6256802. eCollection 2018.


The impact of steatosis on liver regeneration.

Allaire M, Gilgenkrantz H.

Horm Mol Biol Clin Investig. 2018 Nov 21. pii: /j/hmbci.ahead-of-print/hmbci-2018-0050/hmbci-2018-0050.xml. doi: 10.1515/hmbci-2018-0050. [Epub ahead of print] Review.


[Comparison of a commercially available, formula-based nutritional therapy enriched with oats fiber with a non-formula isocaloric therapy to treat non-alcoholic fatty liver disease (NAFLD) - a randomized, controlled intervention trial].

Schweinlin A, Ulbrich S, Stauß S, Teutsch M, Walle H, Basrai M, Bischoff SC.

Z Gastroenterol. 2018 Oct;56(10):1247-1256. doi: 10.1055/a-0668-2891. Epub 2018 Oct 10. German.


Beneficial effects of probiotic combination with omega-3 fatty acids in NAFLD: a randomized clinical study.

Kobyliak N, Abenavoli L, Falalyeyeva T, Mykhalchyshyn G, Boccuto L, Kononenko L, Kyriienko D, Komisarenko I, Dynnyk O.

Minerva Med. 2018 Dec;109(6):418-428. doi: 10.23736/S0026-4806.18.05845-7. Epub 2018 Sep 13.


Aerobic Physical Activity and a Low Glycemic Diet Reduce the AA/EPA Ratio in Red Blood Cell Membranes of Patients with NAFLD.

Tutino V, De Nunzio V, Caruso MG, Bonfiglio C, Franco I, Mirizzi A, De Leonardis G, Cozzolongo R, Giannuzzi V, Giannelli G, Notarnicola M, Osella AR.

Nutrients. 2018 Sep 13;10(9). pii: E1299. doi: 10.3390/nu10091299.

Supplemental Content

Loading ...
Support Center